Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.

NCT01753804 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT01753804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Terminated
Start date
September 1, 2012
Completion date
October 1, 2016
Enrollment
269 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy